These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19705261)

  • 21. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma.
    Tong CY; Khan R; Beeching NJ; Tariq WU; Hart CA; Ahmad N; Malik IA
    Epidemiol Infect; 1996 Oct; 117(2):327-32. PubMed ID: 8870630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.
    Di Poto C; He S; Varghese RS; Zhao Y; Ferrarini A; Su S; Karabala A; Redi M; Mamo H; Rangnekar AS; Fishbein TM; Kroemer AH; Tadesse MG; Roy R; Sherif ZA; Kumar D; Ressom HW
    PLoS One; 2018; 13(3):e0192748. PubMed ID: 29538406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon.
    Andoulo FA; Noah DN; Djapa R; Kowo M; Talla P; Medjo EH; Djomkam IK; Nonga BN; Njoya O; Ndam EC
    Pan Afr Med J; 2014; 19():379. PubMed ID: 25977742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
    Aljumah AA; Kuriry H; Faisal N; Alghamdi H
    Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
    Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
    Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.
    Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R
    J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.
    Tapper EB; Catana AM; Sethi N; Mansuri D; Sethi S; Vong A; Afdhal NH
    Cancer; 2016 Mar; 122(6):852-8. PubMed ID: 26716758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatitis-C virus and hepatoma].
    Zala G; Havelka J; Altorfer J; Joller-Jemelka HJ; Risti B; Meier B; Schmid M; Bühler H
    Schweiz Med Wochenschr; 1992 Feb; 122(6):194-7. PubMed ID: 1311125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
    Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors.
    Wong A; Le A; Lee MH; Lin YJ; Nguyen P; Trinh S; Dang H; Nguyen MH
    Sci Rep; 2018 May; 8(1):7164. PubMed ID: 29740031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout.
    Huang AC; Mehta N; Dodge JL; Yao FY; Terrault NA
    Hepatology; 2018 Aug; 68(2):449-461. PubMed ID: 29476694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis.
    Benvegnù L; Alberti A
    Antiviral Res; 2001 Nov; 52(2):199-207. PubMed ID: 11672830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peginterferon α-2a plus ribavirin in Latino and Non-Latino Whites with HCV genotype 1: Histologic outcomes and tolerability from the LATINO Study.
    Balart LA; Lisker-Melman M; Hamzeh FM; Kwok A; Lentz E; Rodriguez-Torres M;
    Am J Gastroenterol; 2010 Oct; 105(10):2177-85. PubMed ID: 20389293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen.
    Innes H; Barclay ST; Hayes PC; Fraser A; Dillon JF; Stanley A; Bathgate A; McDonald SA; Goldberg D; Valerio H; Fox R; Kennedy N; Bramley P; Hutchinson SJ
    J Hepatol; 2018 Apr; 68(4):646-654. PubMed ID: 29155019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.